In the pharmaceutical industry, the signature of the responsible individual is essential for compliance with (GMP) regulations. However, traditional methods may pose security risks. In a Pharma 4.0 environment, biometrics provides a secure solution, ensuring data integrity and enhancing traceability for more precise regulatory compliance.
In the pharmaceutical industry, the signature of the responsible person is crucial for complying with GMP regulations. However, traditional methods have security and traceability vulnerabilities. Biometrics provides an advanced solution that enhances information integrity and ensures regulatory compliance.
Biometrics has become an essential technology for identification and authentication, ensuring security and efficiency in multiple sectors. Although its adoption has grown, there are still doubts about its operation and benefits, as well as myths surrounding its current application.
Adopting a quality philosophy that goes beyond mere regulatory compliance is essential to standing out in the pharmaceutical industry. The integration of advanced technologies, such as biometrics, represents an effective solution to ensure regulatory compliance and achieve superior quality standards.
Fingerprint biometrics is recognized as a highly secure identification method. Today, its use has expanded beyond the realm of security, and it is widely used to manage identities and control access in a variety of industries.
Biometrics offers a secure, convenient and fast way to identify people. We analyze the characteristics of the main biometric technologies, such as iris, facial and fingerprint recognition, considering the advantages and disadvantages they provide.
Ensuring the integrity of data collected in clinical trials is essential and represents a critical step in the introduction of new drugs to the market. The implementation of biometric electronic signatures in Electronic Data Capture (EDCs) ensures their accuracy and reliability.
The biometric electronic signature within the audit trail action log ensures the integrity of records in GMP regulated environments, providing detailed and reliable tracking of recorded activities.
The pharmaceutical industry must ensure compliance with GMP regulations, which include a number of issues, including data integrity. The adoption of biometric technologies, such as iris or fingerprint recognition, emerges as the solution to ensure compliance.
Within GxP regulated environments, it is essential to ensure data integrity and traceability of actions throughout the supply chain. The adoption of biometric technologies, such as iris or fingerprint recognition, emerges as the solution to ensure compliance.
*Subsidised by CDTI
Verazial Labs, S.L. has participated in the ICEX-Next Export Initiation Program and has received support from ICEX, along with co-financing from European FEDER funds. This support has contributed, in accordance with its scope, to the economic growth of the company, its region, and Spain as a whole.
Copyright © Verázial Labs 2024 – All rights reserved
*Subsidised by CDTI
Verazial Labs, S.L. has participated in the ICEX-Next Export Initiation Program and has received support from ICEX, along with co-financing from European FEDER funds. This support has contributed, in accordance with its scope, to the economic growth of the company, its region, and Spain as a whole.
Copyright © Verázial Labs 2024 – All rights reserved
*Subsidised by CDTI
Verazial Labs, S.L. has participated in the ICEX-Next Export Initiation Program and has received support from ICEX, along with co-financing from European FEDER funds. This support has contributed, in accordance with its scope, to the economic growth of the company, its region, and Spain as a whole.
Copyright © Verázial Labs 2024 – All rights reserved
